BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18474629)

  • 1. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
    Holdener M; Hintermann E; Bayer M; Rhode A; Rodrigo E; Hintereder G; Johnson EF; Gonzalez FJ; Pfeilschifter J; Manns MP; Herrath Mv; Christen U
    J Exp Med; 2008 Jun; 205(6):1409-22. PubMed ID: 18474629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
    Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
    J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2D6 as a model antigen.
    Christen U; Holdener M; Hintermann E
    Dig Dis; 2010; 28(1):80-5. PubMed ID: 20460894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
    Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
    J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
    Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
    J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CYP2D6 animal model: how to induce autoimmune hepatitis in mice.
    Hintermann E; Ehser J; Christen U
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
    Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
    J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adenovirus-induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model.
    Fuchs S; Bayer M; Taubert R; Manns MP; Pfeilschifter JM; Christen U; Hintermann E
    Liver Int; 2019 Dec; 39(12):2330-2340. PubMed ID: 31225929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a New Murine Model of Type 2 Autoimmune Hepatitis Using a Human Liver Protein.
    Thomas-Dupont P; Grube-Pagola P; Izaguirre-Hernández IY; Hernández-Flores KG; Sánchez-Marce EE; Cano-Contreras AD; Remes-Troche JM; Vivanco-Cid H
    Am J Pathol; 2022 Jan; 192(1):21-30. PubMed ID: 34717895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
    Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
    J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
    Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
    Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
    Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
    Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?
    Christen U; Hintermann E
    Front Immunol; 2018; 9():163. PubMed ID: 29503645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
    Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
    J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New animal models for autoimmune hepatitis.
    Christen U; Hintermann E; Jaeckel E
    Semin Liver Dis; 2009 Aug; 29(3):262-72. PubMed ID: 19675999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
    Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of a mouse model of autoimmune hepatitis induced by human CYP2D6].
    Chi G; Ma Q; Pei J; Feng Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Aug; 34(8):690-694. PubMed ID: 30384866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.